Philip Astley-Sparke

Insider Reports History

Location
Woburn, MA
Signature
/s/ Shawn Glidden, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Philip Astley-Sparke:

Company Role Class Num Shares Value Price $ Report Date Ownership
Replimune Group, Inc. Director Common Stock 1,380,071 $10,198,724 $7.39 18 Feb 2026 Direct
enGene Holdings Inc. Director Common Shares 20,000 $65,000 $3.25 08 Jul 2025 Direct
enGene Holdings Inc. Director Stock Option (Right to Buy) 45,000 08 Jul 2025 Direct

Insider Reports Filed by Philip Astley-Sparke

Symbol Company Period Transactions Value $ Form Type Role Filing Time
REPL Replimune Group, Inc. 18 Feb 2026 1 $0 4 Director 20 Feb 2026, 16:15
ENGN enGene Holdings Inc. 08 Jul 2025 1 $0 4 Director 10 Jul 2025, 16:07
ENGN enGene Holdings Inc. 08 Jul 2025 0 $0 3 Director 08 Jul 2025, 16:11
REPL Replimune Group, Inc. 20 May 2025 1 -$260,169 4 Director 22 May 2025, 21:47
REPL Replimune Group, Inc. 30 Aug 2024 1 $0 4 Executive Chairman, Director 30 Aug 2024, 20:00
REPL Replimune Group, Inc. 16 May 2024 1 -$245,394 4 Executive Chairman, Director 20 May 2024, 20:04
REPL Replimune Group, Inc. 16 May 2023 1 -$323,131 4 Chief Executive Officer, Director 18 May 2023, 20:30
REPL Replimune Group, Inc. 01 Apr 2023 2 $0 4 Chief Executive Officer, Director 04 Apr 2023, 20:00
REPL Replimune Group, Inc. 16 May 2022 1 -$140,531 4 Chief Executive Officer, Director 18 May 2022, 19:00
REPL Replimune Group, Inc. 01 Apr 2022 2 $0 4 Chief Executive Officer, Director 05 Apr 2022, 16:18
/report/000095010321019579-astley-sparke-philip-2021-12-09 Forbion European Acquisition Corp. 09 Dec 2021 0 $0 3 Director 09 Dec 2021, 16:37